Centessa Pharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company

Senior Advisor, Regulatory Starting Material

Centessa Pharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company · Boston, MA

Posted 27 days ago · $140,000.00 to $210,000.00 · Previously reposted

or apply directly on Centessa Pharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company 's site. We never take the application ourselves.

Is this posting real?

This role has been open
27 days
Centessa Pharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company 's roles stay open a median of 21 days
Reposted
Yes
taken down and listed again at least once
Salary listed
Yes
90% of Centessa Pharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company 's roles list one
Ghost-job risk at Centessa Pharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company
low
3 stale, 10 reposted of 21 open
Hiring momentum
31 roles opened in the last 90 days
↑ up vs. the prior 90 days
Last confirmed on the employer's board
2026-09-17

Measured from postings appearing on and disappearing from Centessa Pharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company 's own greenhouse board since 2026-08-03. Full hiring picture for Centessa Pharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company .

About this role

The Senior Advisor, Regulatory Starting Material at Centessa Pharmaceuticals will lead the strategy and regulatory positioning of Regulatory Starting Materials for drug substance manufacturing processes. This role involves managing relationships with external partners, authoring regulatory submissions, and ensuring compliance with ICH Q11 guidelines. The individual will collaborate with various departments to support late-stage clinical and commercial programs, while also mentoring a team in CMC strategy activities.

Our read on this posting4.2out of 5
benefits
3/5
freshness
4/5
career value
4/5
role clarity
5/5
pay transparency
5/5

Scored from the posting itself — how clearly the role is described, how much it says about pay and benefits, and how recently it was listed. Not a judgement of Centessa Pharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company as an employer.

What you need

  • Advanced degree in chemistry, chemical engineering, or a related field; PhD strongly preferred
  • 8-10 years of relevant experience in CMC, process chemistry or drug substance/API development and manufacturing
  • Demonstrated experience supporting late-stage clinical and/or commercial drug substance programs
  • Deep working knowledge of ICH Q11 and applicable regional guidance
  • Demonstrated experience authoring and defending CMC regulatory submission content
  • Strong background in synthetic/process chemistry

Nice to have

  • Experience supporting technology transfer of drug substance processes from clinical to commercial scale

What you get

  • Annual base salary range of $140,000.00 to $210,000.00
  • Discretionary annual bonus
  • Comprehensive benefits package including 401(k) plan
  • Company-sponsored medical, dental, vision, and life insurance
  • Generous paid time off
  • Health and wellness program

Worth weighing

  • Salary range provided, but individual compensation will vary based on several factors
  • Role requires domestic and international travel (approximately 10-20%)
  • Mentoring responsibilities may vary based on team scope
  • Position is full-time and exempt, indicating potential for longer hours

Summarised from Centessa Pharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company 's posting. Read the full original.

Listed by Centessa Pharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company on their greenhouse job board, last confirmed open on 2026-09-17. PitchMeAI is not the employer.

More roles at Centessa Pharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company

All 21 open roles at Centessa Pharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company